BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

计划入组 35 人 · 首次发布于 2024 年 1 月 16 日

Unraveling Genetics of HypoPhosPhatasia (HPP Genetics)

计划入组 16 人 · 首次发布于 2021 年 6 月 14 日

The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services

计划入组 170 人 · 首次发布于 2024 年 6 月 12 日

TYK2 Inhibitors (1910 Genetics)

HGP-1910

SL-1910

Opus Genetics

Benin

Functional Genetics, Inc.

United States

Vanilloid Genetics Inc.

Canada

Accenture Invests in Ryght AI to Accelerate Clinical Trial Execution Through Agentic AI Platform

BioInvent Advances BI-1910 Anti-TNFR2 Antibody with Population Modeling Data at PAGE 2025

BioInvent to Present Phase 1 Data for BI-1910 TNFR2 Agonist at SITC Despite Pausing Development